Booth Id:
CELL030
Category:
Cellular and Molecular Biology
Year:
2021
Finalist Names:
Mehta, Neil (School: Ward Melville High School)
Abstract:
lnterleukin-22 (IL-22) is a regulatory cytokine in the IL-10 family. Numerous intestinal cell types including absorptive and secretory cells express IL-22RA1, the IL-22 receptor. Intestinal IL-22 promotes mucosal wound healing, mucus secretion, and antimicrobial peptide (AMP) production. However, heightened IL-22 levels have also been observed in diseases including inflammatory bowel disease (IBD) where it may induce protective or detrimental effects.
The pivotal roles of IL-22 in mediating intestinal functions and inflammatory responses have made it a promising target for therapeutic applications. IL-22 specifically acts on Paneth cells, a lineage of small intestinal secretory cells that secrete AMPs. Paneth cells package AMPs in granules stored in vesicles. IL-22 orchestrates the release of Paneth cell-derived AMPs, which protect against microbial pathogens and have been suggested to support the intestinal stem cell niche.
I observe that IL-22 signaling via Paneth cells promotes intestinal host defense. Using novel Il22ra1fl/fl;Defa6-cre (Paneth cell-specific IL-22RA1 knockout) mice, I demonstrate that IL-22 signaling via Paneth cell-specific IL-22RA1 receptors promotes organoid growth ex vivo. I observe that Paneth cell counts do not vary between Il22ra1fl/fl;Defa6-cre+ and cre- littermate controls. Furthermore, I determine that Paneth cells of Il22ra1fl/fl;Defa6-cre+ and cre- mice display no difference in vesicle counts.
These results suggest that IL-22 signaling via Paneth cell lL-22RA1 promotes epithelial proliferation ex vivo, though it does not directly modify Paneth cell morphology. These findings characterize a previously unclear role of IL-22 in Paneth cell-mediated intestinal defense, contextualizing potential therapeutic applications of IL-22.
Awards Won:
Third Award of $1,000